Home Cart 0 Sign in  

[ CAS No. 868540-15-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 868540-15-2
Chemical Structure| 868540-15-2
Structure of 868540-15-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 868540-15-2 ]

Related Doc. of [ 868540-15-2 ]

Alternatived Products of [ 868540-15-2 ]

Product Details of [ 868540-15-2 ]

CAS No. :868540-15-2 MDL No. :MFCD29044885
Formula : C37H47N3O6 Boiling Point : -
Linear Structure Formula :- InChI Key :AKIABKDAWVWIHO-CPCREDONSA-N
M.W : 629.79 Pubchem ID :58887448
Synonyms :

Calculated chemistry of [ 868540-15-2 ]

Physicochemical Properties

Num. heavy atoms : 46
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.41
Num. rotatable bonds : 21
Num. H-bond acceptors : 6.0
Num. H-bond donors : 3.0
Molar Refractivity : 178.71
TPSA : 122.83 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.1 cm/s

Lipophilicity

Log Po/w (iLOGP) : 5.22
Log Po/w (XLOGP3) : 7.1
Log Po/w (WLOGP) : 5.36
Log Po/w (MLOGP) : 3.79
Log Po/w (SILICOS-IT) : 6.59
Consensus Log Po/w : 5.61

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -7.12
Solubility : 0.0000476 mg/ml ; 0.0000000756 mol/l
Class : Poorly soluble
Log S (Ali) : -9.5
Solubility : 0.0000002 mg/ml ; 0.0000000003 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -10.72
Solubility : 0.0000000119 mg/ml ; 0.0 mol/l
Class : Insoluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 5.55

Safety of [ 868540-15-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 868540-15-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 868540-15-2 ]
  • Downstream synthetic route of [ 868540-15-2 ]

[ 868540-15-2 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 70637-28-4 ]
  • [ 82732-07-8 ]
  • [ 868540-15-2 ]
Reference: [1] Patent: US2005/245435, 2005, A1, . Location in patent: Page/Page column 32-33
  • 2
  • [ 82732-07-8 ]
  • [ 868540-15-2 ]
YieldReaction ConditionsOperation in experiment
24.8 g With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine In acetonitrile at 0 - 30℃; Inert atmosphere COMPARATIVE EXAMPLE 2: Preparation of compound of Formula VII A mixture of 70percent trifluoro acetic acid/methylene chloride (150 ml) was allowed to cool to 0°C. To the reaction mass compound of Formula IV (25g, leq) was added at same temperature. Then the reaction mass was heated to 25-30°C and stirred for 2 hr at same temperature. After completion of reaction, distilled the reaction mass completely under vacuum and the obtained trifluoroacetic acid salt of Formula V was dissolved in acetonitrile (550 ml). To the reaction mass N-boc-homo phenyl alanine (25g, leq) and diisopropyl ethyl amine (27.5g, 4eq) were added at 25-30°C. Reaction mass was allowed to cool to 0°C and HOBt (11.5g, 1.6eq), PyBOP (44.4g, 1.6eq) were added in lot wise over 5 min at same temperature and stirred for overnight under nitrogen at 25-30°C. Then the reaction mass was allowed to cool to 0°C and the solid obtained was filtered, washed with chilled acetonitrile to get the title compound. Yield: 24.8 g; Chemical purity by HPLC: 89.35percent; HOBt: 9.9percent, PyBOP: 0.02percent and tris(pyrrolidino phosphine) oxide: 0.24percent by HPLC.
Reference: [1] Patent: WO2016/185450, 2016, A1, . Location in patent: Page/Page column 68
  • 3
  • [ 140834-91-9 ]
  • [ 82732-07-8 ]
  • [ 868540-15-2 ]
YieldReaction ConditionsOperation in experiment
130 g
Stage #1: With trifluoroacetic acid In dichloromethane at 2 - 30℃; for 2 h;
Stage #2: With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 2 - 30℃;
EXAMPLE 2: Preparation of compound of Formula VII A mixture of methylene chloride (90 ml) and trifluoro acetic acid (210 ml) was allowed to cool to 2-6°C and compound of Formula IV (100 g, leq) was added at same temperature. Then the reaction mass was heated to 25-30°C and stirred for 2 hr at same temperature. To the reaction mass methylene chloride (1.51it) was added and pH adjusted to 7-8 with 20percent sodium carbonate at 25-30°C and stirred for 20 min at same temperature. Separated the organic layer and washed with water (300ml) and 10percent sodium chloride (300 ml) sequentially. Organic layer was separated and concentrated under vacuum at below 35°C to obtain residue. The obtained residue was dissolved in dimethyl formamide (500 ml) and allowed to cool to 2-6°C. To the reaction mass HOBt (2.9g, O.leq), PyBOP (133.5g, 1.2eq), N-boc-homo phenyl alanine (59.7g, leq) were added slowly at 2-6°C. To the reaction mass HOBt (2.9g, O.leq), PyBOP (133.5g, 1.2eq), N-boc-homo phenyl alanine (59.7g, leq) and diisopropyl ethyl amine (110.5g, 4eq) were added slowly at 2-6°C. Then the reaction mass was heated to 25-30°C and stirred for 2-3 hr at same temperature. After completion of the reaction, reaction mass was quenched in to water (51it) at 25-30°C and stirred for 2-3 hr at same temperature and the precipitated solid was filtered, washed with water (500 ml) and dried to get the title compound. Yield: 130g; PXRD: Fig. 2; DSC: endothermic peak at about 150°C; Chemical purity by HPLC: 99.97percent; HOBt: 0.1percent, PyBOP: Not detected and tris(pyrrolidino phosphine) oxide: 0.02percent by HPLC.
Reference: [1] Patent: WO2016/185450, 2016, A1, . Location in patent: Page/Page column 61-62
  • 4
  • [ 13139-15-6 ]
  • [ 868540-15-2 ]
Reference: [1] Patent: WO2016/185450, 2016, A1,
[2] Patent: WO2016/185450, 2016, A1,
  • 5
  • [ 2462-32-0 ]
  • [ 868540-15-2 ]
Reference: [1] Patent: WO2016/185450, 2016, A1,
[2] Patent: WO2016/185450, 2016, A1,
  • 6
  • [ 140834-91-9 ]
  • [ 868540-15-2 ]
Reference: [1] Patent: WO2016/185450, 2016, A1,
Same Skeleton Products
Historical Records